JOSE RENDON-GARCIA: Open Payments
NPI 1083650972 · SAVANNAH, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,141 in 118 payments from 29 companies in 2025. Trend: 2023 $1,782 · 2024 $1,712 · 2025 $2,141
Food & beverage: $2,141
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $343 |
| Novo Nordisk Inc | 24 | $315 |
| AstraZeneca Pharmaceuticals LP | 5 | $178 |
| Lilly USA, LLC | 11 | $161 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $125 |
| Vanda Pharmaceuticals Inc. | 4 | $124 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 6 | $100 |
| Lundbeck LLC | 5 | $95 |
| Amgen Inc. | 4 | $81 |
| Corcept Therapeutics | 2 | $57 |
Products named: VRAYLAR, JARDIANCE, Rybelsus, FANAPT, MOUNJARO, AIRSUPRA, Ozempic, XIFAXAN.
Industry payments across GA — which companies pay providers there.
